The first global consensus on inflammatory bowel disease and pregnancy delivers clinician-focused, evidence-based guidance for real-world practice.
ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback